Current Management of Extensive Stage Small Cell Lung Cancer in Italy: A National Survey on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Alessio Bruni(University of Modena and Reggio Emilia), Paolo Borghetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Marco Galaverni(Istituto Superiore per la Protezione e la Ricerca Ambientale), Stefano Vagge(Ospedale Policlinico San Martino), Francesco Cuccia(Azienda di Rilievo Nazionale ed Alta Specializzazione), Emanuela Olmetto(Azienda Ospedaliero-Universitaria Careggi), Jessica Imbrescia(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Chiara Bennati(Azienda Ospedaliera di Perugia), Ruggero Spoto(IRCCS Humanitas Research Hospital), Emanuele Alì(Azienda Sanitaria Unità Locale di Reggio Emilia), Maria Alessia Zerella(European Institute of Oncology), Federica Bertolini, Marcello Tiseo(University of Parma), Niccolò Giaj‐Levra(Ospedale Sacro Cuore Don Calabria), Antonio Pontoriero(University of Messina), Serena Badellino, Vieri Scotti(University of Florence), M. Miele(Campus Bio Medico University Hospital), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 0
Related Papers
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
|Drug Resistance Updates|2019|198
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
|Annals of Surgical Oncology|2022|162
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146